Description:
Dapagliflozin Impurity 3 is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM).
- Molecular Weight:453.32
- Boiling Point:623.1±55.0°C at 760 mmHg
- Melting Point:63-79°C
- Purity:>95%
Molecular Formula:
C21H25BrO6
Canonical SMILES:
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Br
InChI:
InChI=1S/C21H25BrO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
InChIKey:
UABOQFANGSVXKK-ADAARDCZSA-N
Solubility:
Soluble in Chloroform (Slightly), DMSO (Slightly)
Appearance:
White to Off-white Solid
Storage: Store at -20°C
Synonyms:
USP Dapagliflozin Related Compound A; (2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Dapagliflozin Impurity 3; 4-Deschloro-4-bromo Dapagliflozin; Dapagliflozin 4-bromo Impurity; (1S)-1,5-Anhydro-1-C-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; D-Glucitol, 1,5-anhydro-1-C-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)- Weitere Informationen finden Sie
hier